INFLUENCE OF HORMONE THERAPY ON BODY FLUIDS, ELECTROLYTE BALANCE AND MUCOPOLYSACCHARIDES IN MYXEDEMA*†
- 1 September 1955
- journal article
- research article
- Published by The Endocrine Society in Journal of Clinical Endocrinology & Metabolism
- Vol. 15 (9) , 1131-1140
- https://doi.org/10.1210/jcem-15-9-1131
Abstract
Two female patients, 1 with primary, and 1 with pituitary myxedema were studied. The patient with pituitary myxedema, during thyrotropin treatment, showed expansion of extracellular fluid space (thiosulfate) and total body water (antipyrine), with subsequent contraction of extracellular fluid space. There was an associated slight retention of Na and Cl, and a slight weight loss. During treatment with desiccated thyroid, both patients demonstrated transient expansion of extracellular fluid space with essentially parallel changes in total body water, weight loss, and increased urine volume. Na and Cl balances became negative in the patient with primary myxedema. The other patient showed Na and Cl retention, but to a lesser degree than during the preceding control period. In the patient with primary myxedema there was an increase in urinary hexosamine and a transient increase in the level of serum mucoprotein; in the other patient, there occurred an increase in urinary and serum hexosamine levels at the end of the period. The patient with primary myxedema, under treatment with cortisone prior to thyroid administration, demonstrated moderate expansion of the extracellular fluid space, associated with Na and Cl retention and weight gain. Some rise in the concentration of serum mucoprotein was noted. During combined thyroid-cortisone administration, there occurred greater expansion of extracellular fluid space, and negative Na and Cl balances, with constant weight. The patient with pituitary myxedema, during treatment with thyroid and cortisone, showed transient extracellular space expansion. In both patients there was a considerable increase in urinary hexosamine during combined thyroid-cortisone treatment, not observable in the patient with primary myxedema receiving cortisone alone. There was a slight rise in serum mucopoly-saccharide fractions in both patients during combined therapy.Keywords
This publication has 11 references indexed in Scilit:
- METHOD FOR THE DETERMINATION OF HEXOSAMINES IN TISSUESJournal of Biological Chemistry, 1953
- THE VOLUME OF DISTRIBUTION OF SODIUM THIOSULFATE AS A MEASURE OF THE EXTRACELLULAR FLUID SPACE 1Journal of Clinical Investigation, 1952
- Effect of cortisone and ACTH on fluid and electrolyte distribution in manThe American Journal of Medicine, 1951
- THE SIGNIFICANCE OF THE ADENOHYPOPHYSIS, ADRENAL CORTEX AND THYROID IN RENAL FUNCTION IN MANActa Endocrinologica, 1950
- Effect of the Adrenocorticotropic Hormone of the Pituitary on Mesenchymal TissuesScandinavian Journal of Clinical and Laboratory Investigation, 1950
- THE USE OF ANTIPYRINE IN THE MEASUREMENT OF TOTAL BODY WATER IN MANJournal of Biological Chemistry, 1949
- The Mucopolysaccharide Content of the Skin in Localized (Pretibial) Myxedema. IIAmerican Journal of Clinical Pathology, 1949
- METHODS FOR THE CHEMICAL DETERMINATION OF CORTICOSTEROIDS IN URINE AND PLASMA1948
- SPECIFIC RENAL FUNCTIONS IN HYPERTHYROIDISM AND MYXEDEMAJournal of Clinical Endocrinology & Metabolism, 1947
- A colorimetric method for the determination of glucosamine and chondrosamineBiochemical Journal, 1933